??? INTERVIEW | Unmasking Long COVID with Keith C. Ellis, CEO of Science-Driven Supplements

Listen to the episode on ?? Spotify, ?? Apple Podcasts and ?? Substack Podcasts

On this episode I sit down with Keith C Ellis, PhD,?

Dr. Ellis is an associate professor in the Department of Medicinal Chemistry at Virginia Commonwealth University and a natural products chemist.

He is the founder and CEO of Science-Driven Supplements, where he uses his knowledge of physiology, pharmacology, drugs, and natural products to create products to tackle big public health challenges.?

Keith was frustrated with the treatment options for long COVID, and used his expertise in natural product chemistry to reverse engineer a solution based on the positive results shown from using anticoagulant drugs to treat long COVID.

The resulting product is called CircuGuard, which combines three natural ingredients that target the same biological pathways as triple anticoagulant therapy, in a dose which is safe for over-the-counter use.

Listen to the episode on Spotify, Apple Podcasts or Substack Podcasts to learn the origin story of CircuGuard and how Keith came up with this solution to help the millions suffering from long COVID.

Key Takeaways:

• There are over 400 million cases of long COVID projected worldwide.
• Long COVID symptoms are diverse and not well-defined, therefore patients often experience frustration due to lack of clear diagnostics.?
• A new hypothesis suggests that microclots in the blood cause long COVID symptoms.
• Unfortunately, testing for microclots is currently limited and not widely available.
• Triple anticoagulant therapy shows promise but has safety concerns, and CircuGuard aims to provide a safer treatment option using natural anticoagulants for the treatment of long COVID.
• Real-life testimonials highlight the positive impact of Circugard on long COVID symptoms.
• Users are advised to take Circugard for three to six months for best results.

Listen now on Apple Podcasts, Spotify, and Substack Podcasts.

Recommended Timestamps

• 00:00 Introduction to Long COVID Research
• 06:00 The Microclots Hypothesis
• 11:58 Testing and Treatment for Microclots
• 22:24 Reverse Engineering Pharmaceutical Therapy
• 28:37 CircuGuard: Market Launch and Mission
• 34:50 Long COVID Treatment: Expectations and Recommendations
• 43:49 Advice for Entrepreneurs in Long COVID Research

Where to find Keith C. Ellis, PhD:

• LinkedIn
• Keith C Ellis’ Website
• CircuGuard Website
• Science Driven Supplements

Where to find Nina Patrick, PhD:

• Newsletter
• LinkedIn?
• Website

Thanks for listening to Nina’s Notes. If you like this newsletter & podcast, click the share button and send it to a friend.

Edited by Wright Time Publishing